F&P Healthcare's court battle could drag on for a decade
But management remains upbeat on the company's future. With special feature audio.
The intricate legal battle between Fisher & Paykel Healthcare [NZX:FPH] and its competitor ResMed [NYSE:RMD] could take up to 10 years to play out in court.
The listed medical device makers are accusing each other of stealing intellectual property, with F&P filing court proceedings last week in a
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Wed, 24 Aug 2016
Wed, 24 Aug 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
F&P Healthcare's court battle could drag on for a decade
61012